# Medical Stop Loss Insurance â€” Market Research

*Prepared by Nova ðŸ“Š | February 2026*

---

## 1. What Is Medical Stop Loss Insurance?

Medical stop loss (also called excess loss) insurance protects **self-funded employers** from catastrophic or higher-than-expected health claim costs. When an employer self-funds its health plan, it assumes the financial risk of paying employee medical claims directly. Stop loss acts as a reinsurance safety net.

### Specific (Individual) Stop Loss
- Protects against **high-cost individual claims**
- Employer selects a **specific deductible** (attachment point), typically $50Kâ€“$500K+ per claimant per year
- Once an individual's claims exceed that threshold, the stop loss carrier reimburses the excess
- Example: With a $150K specific deductible, if one employee incurs $800K in claims, the carrier pays $650K

### Aggregate Stop Loss
- Protects against **total plan claims exceeding expected levels**
- Attachment point is typically set at **120â€“125% of expected annual claims**
- If the employer's total claims for all employees exceed the aggregate corridor, the carrier reimburses the excess
- Provides budget predictability and caps worst-case scenario

### How They Work Together
Most self-funded employers purchase **both** specific and aggregate coverage. Specific handles the shock claims (cancer, organ transplants, premature births); aggregate handles the scenario where overall utilization trends higher than projected.

---

## 2. Market Size & Growth

### Current Market
- **U.S. medical stop loss market:** estimated at **$25â€“30 billion** in annual premium (2024â€“2025)
- The market has grown at a **8â€“12% CAGR** over the past five years, driven by:
  - More employers moving to self-funding
  - Medical cost inflation (6â€“10% annually)
  - Rising specialty drug costs (gene therapies, GLP-1s, cell & gene therapies exceeding $1M+)
  - Lower specific deductibles as employers seek more protection

### Self-Funded Employer Growth
- **~60% of covered workers** in the U.S. are in self-funded plans (up from ~44% in 2000)
- Among large employers (500+ employees): **~80% self-fund**
- Growing adoption among **mid-market (100â€“500 employees)** through level-funded and captive arrangements
- Estimated **35,000â€“40,000+ self-funded employer groups** in the U.S.

### Key Growth Drivers
1. **Medical cost inflation** â€” higher claims = higher premiums and more demand for protection
2. **Cell & gene therapy costs** â€” single claims now regularly exceed $1Mâ€“$3M+
3. **GLP-1 medications** (Ozempic, Wegovy, Mounjaro) â€” adding billions in plan costs
4. **Mid-market migration** to self-funding â€” expands the addressable market
5. **Employer desire for cost transparency** â€” self-funding + stop loss vs. fully insured opacity

---

## 3. Key Players & Competitive Landscape

### Tier 1 â€” Major Stop Loss Carriers
| Carrier | Notable Strengths |
|---------|-------------------|
| **Sun Life** | #1 or #2 market share; strong TPA relationships; broad distribution |
| **Voya Financial** | Major player post-acquisition of stop loss books; strong mid-market |
| **Berkshire Hathaway Specialty** | Leverages BH balance sheet; competitive on large/complex risks |
| **HM Insurance Group (Highmark)** | Top-tier; strong in managing large claims; integrated analytics |
| **Symetra (Sumitomo)** | Growing aggressively; competitive pricing; strong broker relationships |

### Tier 2 â€” Significant Competitors
| Carrier | Notable Strengths |
|---------|-------------------|
| **Swiss Re Corporate Solutions** | Global reinsurer entering direct; capacity advantage |
| **QBE North America** | Growing stop loss book; niche focus |
| **Tokio Marine HCC** | Specialty risk expertise; strong underwriting |
| **Armada Risk Partners** | MGU model; innovative products |
| **AccuRisk Solutions** | Tech-forward MGU; level-funded and small group focus |

### Tier 3 â€” Emerging / Niche Players
- **Captive stop loss** programs (group captives like Roundstone, Pareto Captive)
- **Insurtech entrants** leveraging data analytics and AI underwriting
- **MGUs/MGAs** â€” growing channel; underwrite on behalf of rated carriers
- **Reinsurers** providing capacity behind MGUs (Swiss Re, Munich Re, Transatlantic Re)

### Distribution Landscape
- **Brokers/Consultants** â€” primary distribution channel (~80%+ of placements)
  - Large: Marsh, Aon, WTW, Gallagher, Lockton
  - Regional/specialty: EPIC, Acrisure, NFP, USI
- **TPAs (Third Party Administrators)** â€” often have preferred stop loss carrier relationships
  - Major TPAs: Meritain Health, HealthSCOPE Benefits, Allegiance, CoreSource, WEB-TPA
- **Direct/Captive arrangements** â€” growing but still <10% of market

---

## 4. Target Customers

### Primary: Self-Funded Employers
- **Mid-market (100â€“1,000 employees):** Fastest-growing segment; moving from fully insured; need education and hand-holding; lower deductibles ($50Kâ€“$150K)
- **Large employers (1,000â€“10,000):** Sophisticated buyers; price-sensitive; higher deductibles ($200Kâ€“$500K); value analytics and service
- **Jumbo employers (10,000+):** Often use aggregate-only or high-deductible specific; may self-insure the specific layer entirely

### Secondary: TPAs
- Administer self-funded plans; need stop loss partners who integrate smoothly
- Value: fast claims reimbursement, easy reporting, competitive rates for their clients
- **Sticky relationships** â€” TPA partnerships drive volume

### Tertiary: Brokers & Consultants
- Advise employers on plan design and stop loss placement
- Value: competitive markets, quick quoting, strong claims advocacy
- Brokers control placement decisions for most mid-market and large groups

### Emerging: Level-Funded / Small Group
- Employers with 25â€“100 employees using level-funded products
- Stop loss is embedded but still underwritten
- Growing rapidly as small employers seek fully insured alternatives

---

## 5. Pain Points & Opportunities

### Employer Pain Points
1. **Unpredictable costs** â€” shock claims from high-cost drugs and conditions
2. **Rate volatility** â€” stop loss renewals with 20â€“50%+ increases after bad years
3. **Lack of transparency** â€” opaque pricing and claims data from carriers
4. **Slow claims reimbursement** â€” cash flow impact when carriers are slow to pay
5. **Complex policy language** â€” lasers, exclusions, and limitations hard to understand
6. **Gene therapy fear** â€” single claims of $2M+ are now realistic; employers feel exposed

### TPA Pain Points
1. **Carrier integration** â€” clunky data exchange and reporting
2. **Reimbursement speed** â€” clients blame the TPA when the carrier is slow
3. **Market access** â€” limited carriers willing to quote their blocks
4. **Service inconsistency** â€” underwriter turnover and process changes

### Broker Pain Points
1. **Quoting turnaround** â€” need fast, accurate quotes to win business
2. **Market capacity** â€” fewer carriers willing to quote difficult risks
3. **Claims advocacy** â€” need a carrier that pays claims without fighting
4. **Differentiation** â€” hard to stand out when selling commodity products

### Market Opportunities
1. **Technology/Data Analytics** â€” AI-driven underwriting, predictive modeling, real-time dashboards
2. **Speed & Service** â€” faster quoting, faster claims payment, better communication
3. **Transparency** â€” clear pricing, no hidden exclusions, open data sharing
4. **Specialty Risk Solutions** â€” gene therapy riders, carve-out programs, captive solutions
5. **Mid-Market Growth** â€” enormous untapped market of employers moving to self-funding
6. **Embedded/Integrated Products** â€” stop loss built into TPA platforms seamlessly
7. **Captive & Alternative Risk** â€” group captives, cell captives as premium-saving vehicles

---

## 6. Industry Trends (2025â€“2027)

### Pricing & Underwriting
- **Hardening market** â€” rates increasing 10â€“25% annually due to medical inflation
- **Lasering** becoming more common â€” carriers excluding known high-cost claimants
- **Lower attachment points** â€” employers buying down deductibles for more protection
- **Gene therapy exclusions/sublimits** â€” carriers adding specific provisions

### Technology
- **AI underwriting** â€” automated risk assessment and pricing
- **Predictive analytics** â€” identifying high-risk claimants before they become shock claims
- **Digital quoting platforms** â€” real-time quotes reducing turnaround from days to hours
- **Claims automation** â€” faster adjudication and reimbursement

### Product Innovation
- **Level-funded products** expanding into larger group sizes
- **Captive solutions** becoming mainstream for mid-market
- **Pharmacy carve-out** programs to manage GLP-1 and specialty drug exposure
- **Reference-based pricing** integration with stop loss
- **Specific advance funding** â€” carriers advancing payment on known large claims

### Distribution
- **MGU/MGA channel growing** â€” carriers deploying capacity through specialized underwriting shops
- **Direct-to-TPA** relationships strengthening
- **Broker consolidation** â€” fewer, larger brokers controlling more premium

---

## 7. Regulatory Environment

- Stop loss is regulated at the **state level** â€” varies significantly by state
- **Minimum attachment point laws** in some states (e.g., $10Kâ€“$40K minimums to prevent look-alike fully insured products)
- **ERISA preemption** generally protects self-funded plans from state insurance mandates
- **ACA considerations** â€” stop loss is not subject to ACA rating rules but faces regulatory scrutiny
- **State-specific filing requirements** â€” policy forms and rates may need state approval

---

## 8. Key Metrics & Benchmarks

| Metric | Typical Range |
|--------|---------------|
| Specific deductible (mid-market) | $50Kâ€“$200K |
| Specific deductible (large group) | $150Kâ€“$500K+ |
| Aggregate attachment | 120â€“125% of expected claims |
| Stop loss premium as % of expected claims | 8â€“15% (varies by deductible) |
| Loss ratios (carrier target) | 70â€“80% |
| Shock claim frequency | 8â€“12% of claimants exceed $100K |
| Average large claim cost | $250Kâ€“$500K |
| Mega claim (>$1M) frequency | Growing 15â€“20% YoY |

---

*Sources: Industry knowledge, SIIA data, carrier reports, broker surveys. Web search unavailable at time of compilation â€” recommend validating specific figures with current SIIA, Sun Life, and HM Insurance reports.*
